December 6, 2023
RegMed Investors (RMi) Closing Bell: “uncle algo and his electronic dwarfs” on back of ADP report
December 5, 2023
RegMed Investors (RMi) Closing Bell: what strength (?) another right thesis yet again
December 4, 2023
RegMed Investors (RMi) Closing Bell: share pricing merry-go-round starts the week
December 1, 2023
RegMed Investors (RMi) Closing Bell: I love drama of market and sector ascensions, tells me … gotta sell some
November 30, 2023
RegMed Investors (RMi) Closing Bell: November is over, wrapping up a best month since 2022
November 29, 2023
RegMed Investors (RMi) Closing Bell: good and bad news shakes the share pricing tree
November 28, 2023
RegMed Investors (RMi) Closing Bell: tug-of-war between red and green rope that closed gray
November 27, 2023
RegMed Investors (RMi) Closing Bell: Cell and gene therapy sector slips
November 25, 2023
RegMed Investors (RMi) Closing Bell: bada, bing, bada-boom
November 16, 2023
RegMed Investors (RMi) Closing Bell: weak companies combine to stay afloat as profiteering breaks the sector
November 15, 2023
RegMed Investors (RMi) Closing Bell: don’t sell until you see the further greening of upsides
November 14, 2023
RegMed Investors (RMi) Closing Bell: a reverse from 4 past loosing sessions, are short positions being covered?
November 13, 2023
RegMed Investors (RMi) Closing Bell: the curse of trial results
November 10, 2023
RegMed Investors (RMi) Closing Bell: the cell and gene therapy sector suffers from…
November 9, 2023
RegMed Investors (RMi) Closing Bell: sector fizzles following a Wednesday sputter
November 8, 2023
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector is punished for LPS (loss-per-share) in earnings season
November 7, 2023
RegMed Investors (RMi) Closing Bell: tailwinds pop the sector
November 6, 2023
RegMed Investors (RMi) Closing Bell: should have read the morning post and followed the lead
November 3, 2023
RegMed Investors (RMi) Closing Bell: are the unknowns known?
November 2, 2023
RegMed Investors (RMi) Closing Bell: sector rallies … again
November 1, 2023
RegMed Investors (RMi) Closing Bell: Cell and gene therapy sector is still not out of the woods
October 31, 2023
RegMed Investors (RMi) Closing Bell: sector jumps saying good-bye to October
October 27, 2023
RegMed Investors (RMi) Closing Bell: Another trip to the abyss, reason - the economy
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.